Takashi Inoue

Dr. Takashi Inoue

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
HTHidehiko Taguchi
Hidehiko Taguchi
TTToshihiro Tanaka
Toshihiro Tanaka
HNHideyuki Nishiofuku
Hideyuki Nishiofuku
YFYasushi Fukuoka
Yasushi Fukuoka
KMKiyoyuki Minamiguchi
Kiyoyuki Minamiguchi
KKKimihiko Kichikawa
Kimihiko Kichikawa

13 June 2015 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
TITakashi Inoue
Takashi Inoue
MCMasayuki Chida
Masayuki Chida
HIHirohisa Inaba
Hirohisa Inaba
MTMotohiko Tamura
Motohiko Tamura
SKSatoru Kobayashi
Satoru Kobayashi
TSTetsu Sado
Tetsu Sado
Catamenial pneumothorax (CP) is a type of spontaneous pneumothorax due to thoracic endometriosis occurring in reproductive women, and usually involves the right side of the thorax showing diaphragm lesions. For the present study, we defined juvenile CP (JCP) as patients with CP who were 19 years old and younger. Institutional findings and a systematic literature review are presented. We retrospectively enrolled all patients with CP treated at our institutions from January 2002 to June 2013. In addition, we conducted a search of medical literature published using the PubMed and Japanese Ichushi databases with “catamenial pneumothorax” as the search term. Thirteen female patients with CP, 1 on the left side, were treated at our institutions. The patient with left-side CP was classified as JCP, while that was also identified in 29 of 451 CPs reported in our literature review. Pneumothorax occurred more frequently on the left side in JCP as compared to usual CP (p<0.01). There was a significantly lower ratio of JCP cases with diaphragm lesions as compared to usual CP (p<0.01). Significant laterality was not seen in JCP patients and fewer had diaphragm lesions as compared to usual CP. JCP may be a new entity of CP.

15 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
KMKiyoyuki Minamiguchi
Kiyoyuki Minamiguchi
HNHideyuki Nishiofuku
Hideyuki Nishiofuku
NSNatsuhiko Saito
Natsuhiko Saito
TSTakeshi Sato
Takeshi Sato
RTRyosuke Taiji
Ryosuke Taiji
TTToshihiro Tanaka
Toshihiro Tanaka
Background: In the era of local and systemic therapies for intermediate-stage hepatocellular carcinoma (HCC), personalized therapy has become available. The aim of our study was to evaluate the usefulness of quantitative analysis of pretreatment gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) to predict prognosis following transarterial chemoembolization (TACE). Methods: This retrospective study included patients with treatment-naïve intermediate-stage HCC who underwent EOB-MRI before the initial TACE and were treated by initial TACE between February 2007 and January 2016. Signal heterogeneity in the hepatobiliary phase (HBP) of EOB-MRI was quantitatively evaluated by the coefficient of variation (CV). The cutoff CV value was determined using the Classification and Regression Tree algorithm. Results: A total of 64 patients were enrolled. In multivariate analysis, High CV (≥0.16) was significantly associated with poor prognosis (p = 0.038). In a subgroup analysis of patients within up-to-7 criteria, MST was significantly shorter in the High CV group than in the Low CV group (37.7 vs. 82.9 months, p = 0.024). In patients beyond up-to-7 criteria, MST was 18.0 and 38.3 months in the High CV and Low CV groups, respectively (p = 0.182). In both groups scanned at 1.5 T or 3.0 T, High CV was significantly associated with poor prognosis (p = 0.001 and 0.003, respectively). Conclusion: CV of the tumor in the HBP of EOB-MRI is a valuable prognostic factor of TACE.

1 September 2012 in Clinical Nephrology
Verified
Journal Article
Closed access
YKY. Kikumoto
Y. Kikumoto
HSHitoshi Sugiyama
Hitoshi Sugiyama
HMHiroshi Morinaga
Hiroshi Morinaga
TITakashi Inoue
Takashi Inoue
KTK. Takiue
K. Takiue
HMH. Makino
H. Makino
Fabry disease (FD) is an Xlinked disorder resulting in a deficiency in α-galactosidase A (α-Gal) activity. FD is one of the causes of progressive renal dysfunction, but its diagnosis is often delayed or missed completely. We herein report the case of a 70-year-old male who had been receiving hemodialysis (HD) for 23 y who was diagnosed with FD after his participation in a screening program for plasma α-Gal activity for 892 HD patients. He had a low plasma α-Gal activity level and was demonstrated to have an E66Q mutation in exon 2 of the α-Gal gene. One of his daughters had the same mutation. The proband died due to aspiration pneumonia before receiving enzyme replacement therapy. We reviewed previous studies and found E66Q mutation in 36% of Japanese FD patients on HD including the present case. The clinical characteristics of E66Q variant are also discussed.

29 June 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
ASAkihiko Shibamoto
Akihiko Shibamoto
TNTadashi Namisaki
Tadashi Namisaki
JSJunya Suzuki
Junya Suzuki
TKTakahiro Kubo
Takahiro Kubo
SISatoshi Iwai
Satoshi Iwai
HYHitoshi Yoshiji
Hitoshi Yoshiji
Alcohol is a major risk factor of liver cirrhosis (LC). This study aimed to elucidate a surrogate marker of sarcopenia in patients with LC of different etiology. Out of 775 patients with LC, 451 were assessed for handgrip strength and skeletal muscle mass (by computed tomography). They were then divided into two groups: alcoholic cirrhosis (AC; n = 149) and nonalcoholic cirrhosis (NAC; n = 302). Endotoxin activity (EA) levels were measured with an EA assay. Group AC showed significantly higher platelet counts (p = 0.027) and lower blood urea nitrogen levels and fibrosis-4 index than group NAC (p = 0.0020 and p = 0.038, respectively). The risk factors of sarcopenia were age ≥ 65 years, female sex, CP-C LC, Hb levels < 12 g/dL, and EA level > 0.4 in all patients with LC; hemoglobin (Hb) levels < 12 g/dL and EA level > 0.4 in group AC; and age ≥ 65 years, CP-C LC, and Hb levels < 12 g/dL in group NAC. The prediction accuracy of Hb for sarcopenia in group AC, group NAC, and all patients was 83.6%, 75.9%, and 78.1% (sensitivity: 92.0%, 69.0%, and 80.2%; specificity: 66.4%, 71.0%, and 64.0%), respectively. Although not significant, the predictive performance was better when using the combination of Hb and EA measurements than when using Hb alone in group AC but was comparable in all patients. Hb levels can predict sarcopenia in patients with LC, but in those with AC, the combination of Hb and EA improves the prediction performance.

1 April 2022 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
AUAtsushi Ugajin
Atsushi Ugajin
SIShinichi Iwakoshi
Shinichi Iwakoshi
SIShigeo Ichihashi
Shigeo Ichihashi
TITakashi Inoue
Takashi Inoue
TNTakahiro Nakai
Takahiro Nakai
KKKimihiko Kichikawa
Kimihiko Kichikawa